医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Cook Medical’s Leadership Updates in Asia-pacific Reinforce Focus on Growth and Physician Relationships

2019年11月13日 AM09:00
このエントリーをはてなブックマークに追加


 

HONG KONG

Cook Medical announced today that Jean-Marc Creissel has been named vice president and director of Asia-Pacific.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191112006126/en/

Jean-Marc Creissel, vice president and director of Cook Medical Asia-Pacific. (Photo: Business Wire)

Jean-Marc Creissel, vice president and director of Cook Medical Asia-Pacific. (Photo: Business Wire)

In his new role, Creissel will lead the Asia-Pacific teams to transform Cook Medical into a truly modern global company with patients, customers and employees at the heart of daily operations. He will grow the teams’ capabilities to help deliver innovative medical solutions and enhance patient care worldwide.

“Jean-Marc has a deep understanding of the Asia-Pacific region because he has served Cook Medical in various positions for nearly 30 years,” said Pete Yonkman, president of Cook Group and Cook Medical. “We are confident that he will continue to expand opportunities for physicians in this region to access Cook’s highly advanced and minimally invasive devices.”

Creissel joined Cook in 1990 and has led several global and regional teams in the USA, Europe and Asia-Pacific regions. His work includes being the global business leader of Cook Medical’s Urology specialty and, most recently, vice president of operations in Greater China and Southeast Asia. Creissel will remain based in Hong Kong.

Creissel succeeds Barry Thomas, who is stepping toward retirement after more than 10 years of leadership in the region. Thomas will focus on his role as vice president and representative director of Cook Japan, where he will advise operations and strategic planning. He will align the needs of the local team with the regional and global functions that support physician connections in Japan. Thomas will remain based in Australia and will have dedicated time spent in the Cook Japan office.

Thomas has 19 years of experience in various leadership roles at Cook Medical. He was appointed vice president and director of Asia-Pacific in 2008, driving the company to grow and expand its business in the region. Additionally, he has over 35 years of expertise and international leadership in the medical device and pharmaceutical industries.

“On behalf of Cook Group, I thank Barry for his tremendous dedication to serving patients in the region,” continued Yonkman. “Under his leadership, our team in Asia Pacific has grown from 60 people to more than 600 in the last 10 years. We are grateful that Barry will lead and coach our teams in Japan, one of our significant areas for growth in Asia.”

About Cook Medical

Since 1963, Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities.

Find out more at www.cookmedical.com, or on social media:
Facebook www.facebook.com/CookMedicalAUS
Twitter @CookMedicalAPAC
LinkedIn linkedin.com/company/cookmedicalapac

Further interviews and hi-res pictures are available on request.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191112006126/en/

CONTACT

Barbara Yeung

Manager, Corporate Brand and Communications, Asia Pacific, Cook Medical

Email: barbara.yeung@cookmedical.com

Phone: +852.9191.5037

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease